Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3223]

Cancer breakthrough - a blood sample 24 hours after start of chemotherapy predicts survival

Cancer breakthrough - a blood sample 24 hours after start of chemotherapy predicts survival

New biomarker for early prediction of response to CAR-T cell therapy

New biomarker for early prediction of response to CAR-T cell therapy

$FDA grants accelerated approval to mosunetuzumab-axgb for relapsed or refractory follicular lymphoma$

FDA grants accelerated approval to mosunetuzumab-axgb for relapsed or refractory follicular lymphoma

Study reveals how chronic blood cancer transitions to aggressive disease

Study reveals how chronic blood cancer transitions to aggressive disease

Experts explain treatment options for a common cancer complication

Experts explain treatment options for a common cancer complication

COVID-19 vaccination protects people with blood cancer

COVID-19 vaccination protects people with blood cancer

World's first clinical trial with CAR-T technology for patients with T-cell leukaemia subtype authorised

World's first clinical trial with CAR-T technology for patients with T-cell leukaemia subtype authorised

ASH 2022: Striving to improve treatment options for acute myeloid leukaemia

ASH 2022: Striving to improve treatment options for acute myeloid leukaemia

Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients

Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients

ASH 2022: Blinatumomab further improves survival among B-lineage ALL patients with a good prognosis

ASH 2022: Blinatumomab further improves survival among B-lineage ALL patients with a good prognosis

More from ecancer